TG Therapeutics, Inc. (TGTX)
35.37
-1.25
(-3.41%)
USD |
NASDAQ |
Apr 27, 16:00
35.37
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Market Cap : 5.648B for April 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Precision BioSciences, Inc. | 173.33M |
| Krystal Biotech, Inc. | 8.021B |
| Catalyst Pharmaceuticals, Inc. | 3.573B |
| Geron Corp. | 973.63M |
| Viking Therapeutics, Inc. | 3.810B |
Market Cap Related Metrics
| PE Ratio | 12.74 |
| PS Ratio | 9.264 |
| PEG Ratio | 0.0068 |
| Price to Book Value | 8.716 |
| Price | 35.37 |
| Earnings Yield | 7.85% |
| PEGY Ratio | 0.0068 |
| Operating PE Ratio | 46.30 |
| Normalized PE Ratio | 12.73 |